Strides Arcolab gets USFDA approval for generic cancer drug
Quotes

Strides Arcolab gets USFDA approval for generic cancer drug

Last Updated: Thursday, November 29, 2012, 15:02
 
 Comment 0
 
Strides Arcolab gets USFDA approval for generic cancer drug
New Delhi: Strides Arcolab Thursday said its wholly-owned arm Onco Therapies has received approval from US health regulator for its generic version of cancer drug Ifosfamide.

The abbreviated new drug approval (ANDA) by US Food and Drug Administration is for Ifosfamide injection in multiple strengths of 50 mg/mL packaged in 1 gram/20 mL and 3 grams/60 mL single-dose vials, the company said in a statement.

Ifosfamide is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch, it added.

Citing IMS data, Strides Arcolab said the US market for generic Ifosfamide is approximately USD 15 million.

Ifosfamide is a chemotherapy drug that is usually used to treat sarcoma, testicular cancer and some types of lymphomas. Occasionally, it may be used to treat other types of cancer, it added.

PTI



First Published: Thursday, November 29, 2012, 15:02


Comments


comments powered by Disqus
World Economic Forum 2015
World Economic Forum 2015
G20 Summit 2014
G20 Summit 2014
2014`s Top People in Business: Fortune
2014`s Top People in Business: Fortune
World Bank`s Top 10 Places for Business
World Bank`s Top 10 Places for Business
India`s top ten billionaires
India`s top ten billionaires

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved